Omega Fund VI L.P. 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 4:43 pm Sale | 2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Omega Fund VI L.P. | 0 0.000% | -2,415,050 (Position Closed) | Filing |
2023-02-13 4:46 pm Unchanged | 2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Omega Fund VI L.P. | 2,415,050 5.200% | 0 (Unchanged) | Filing |
2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Omega Fund VI L.P. | 2,415,050 8.200% | 2,415,050 (New Position) | Filing |